肢端痣的突变谱调查
本研究对49例患者的50个肢端痣标本进行靶向下一代测序,发现BRAF突变高发(43个),NRAS突变较低(5个),且二者互斥;肢端痣的BRAF突变率与日光暴露部位获性痣相似,但远高于肢端黑色素瘤。
要点
- 肢端痣中BRAF突变常见(43/50),NRAS突变少见(5/50),二者互斥。
- 肢端痣的BRAF突变率与日光暴露部位获性痣相似,但远高于肢端黑色素瘤。
- 肢端痣的突变谱与肢端黑色素瘤的已知突变谱不同。
核心结论
- 肢端痣高发BRAF突变,且与NRAS突变互斥,其突变谱与肢端黑色素瘤不同。
研究设计与样本
- 队列研究,对50个肢端痣标本进行靶向下一代测序,标本来自三级学术癌症中心和大学皮肤科诊所的病理档案。
- 部分样本进行BRAF V600E突变的免疫组化染色。
主要发现
- 50个痣来自49例患者(19男30女;中位年龄48岁,范围13-85岁)。
- 测序发现BRAF突变43个,NRAS突变5个,BRAF与NRAS突变互斥。
临床怎么用
- 肢端痣的BRAF突变率高,提示其与肢端黑色素瘤的分子发病机制可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acral skin may develop nevi, but their mutational status and association with acral melanoma is unclear. OBJECTIVE: To perform targeted next-generation sequencing on a cohort of acral nevi to determine their mutational spectrum. DESIGN, SETTING, AND PARTICIPANTS: Acral nevi specimens (n = 50) that had been obtained for diagnostic purposes were identified from the pathology archives of a tertiary care academic cancer center and a university dermatology clinic. Next-generation sequencing was performed on DNA extracted from the specimens, and mutations called. A subset of samples was stained immunohistochemically for the BRAF V600E mutation. RESULTS: A total of 50 nevi from 49 patients (19 males and 30 females; median [range] age, 48 [13-85] years) were examined. Analysis of the sequencing data revealed a high prevalence of BRAF mutations (n = 43), with a lower frequency of NRAS mutations (n = 5). Mutations in BRAF and NRAS were mutually exclusive. CONCLUSIONS AND RELEVANCE: In this cohort study, nevi arising on mostly sun-protected acral skin showed a rate of BRAF mutation similar to that of acquired nevi on sun-exposed skin but far higher than that of acral melanoma. These findings are in contrast to the well-characterized mutational landscape of acral melanoma.
引用
- Smalley KSM, Teer JK, Chen YA, et al. A Mutational Survey of Acral Nevi. JAMA Dermatol. 2021. PMID: 33978681. doi:10.1001/jamadermatol.2021.0793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。